CutisPharma names Neal Muni as Chief Executive Officer President Is Promoted at Wilmington-based Specialty Pharmaceutical Firm
CutisPharma Closes Equity Financing with Ampersand CutisPharma, a specialty pharmaceutical company focusing on the development and commercialization of value-added kits for the compounding pharmacy market,...
In its May 4, 2015 “FDB Customer Connection,” First Databank (FDB) announced a decision to remove CutisPharma’s compounding kits from FDB’s MedKnowledge Database as of June 8, 2015. We believe FDB’s actions are ill-considered, based on mistaken assumptions about the facts and... READ MORE
Read the White Paper
As pharmaceutical compounding continues to grow and evolve, there will be many innovations that will come to enable pharmacists to compound more accurately and more efficiently.
Compounding kits are one example as described in this paper. READ MORE